Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli

Toxins (Basel). 2014 Jun 10;6(6):1799-812. doi: 10.3390/toxins6061799.

Abstract

Enterotoxigenic Escherichia coli (ETEC) are a leading cause of diarrheal illness in developing countries. Despite the discovery of these pathogens as a cause of cholera-like diarrhea over 40 years ago, and decades of vaccine development effort, there remains no broadly protective ETEC vaccine. The discovery of new virulence proteins and an improved appreciation of the complexity of the molecular events required for effective toxin delivery may provide additional avenues to pursue in development of an effective vaccine to prevent severe diarrhea caused by these important pathogens.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Neutralizing / therapeutic use
  • Biological Transport
  • Dysentery / immunology
  • Dysentery / microbiology
  • Dysentery / prevention & control
  • Enterotoxigenic Escherichia coli / immunology*
  • Enterotoxigenic Escherichia coli / physiology
  • Enterotoxins / antagonists & inhibitors*
  • Enterotoxins / metabolism
  • Escherichia coli Infections / immunology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / prevention & control
  • Escherichia coli Proteins / antagonists & inhibitors
  • Escherichia coli Proteins / metabolism
  • Escherichia coli Vaccines / therapeutic use*
  • Host-Pathogen Interactions
  • Humans
  • Virulence Factors / antagonists & inhibitors
  • Virulence Factors / metabolism

Substances

  • Antibodies, Neutralizing
  • Enterotoxins
  • Escherichia coli Proteins
  • Escherichia coli Vaccines
  • Virulence Factors